tirzepatide weight loss trials as Compared with Semaglutide for the Treatment of Obesity What Is Tirzepatide Used for?

Clinical trial data from the SUSTAIN programme, which evaluated semaglutide efficacy and safety, indicated that injection site reactions were generally mild to moderate in severity and transient in nature

Semaglutide may be an excellent fit for individuals who: Have a BMI of 30+, or 27+ with related health concerns such as hypertension or type 2 diabetes Have struggled to lose weight despite healthy eating and consistent exercise Are committed to long-term lifestyle changes Have no history of severe allergic reactions to Semaglutide Dont let excessive weight hold you back any longertake the first step towards a healthier, more vibrant life

Step Three Preventing Relapse aims to prevent the recurrence of binge eating and to support maintaining a healthy weight

A few things help with this window

When Weight Loss Becomes Measurable Measurable weight loss typically appears on the scale between weeks 24 of consistent semaglutide use, though some patients require 48 weeks to see significant change